
Catalyst Pharmaceuticals CPRX
Catalyst Pharmaceuticals PEG | CPRX
PEG Jährlich Catalyst Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.304 | 0.318 | -1.88 | 5.18 | -0.904 | -0.212 | 0.0698 | 0.13 | -3.57 | -0.417 | 1.78 | -1.36 | 0.0801 | -0.0769 | 0.116 | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.18 | -3.57 | -0.029 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Crinetics Pharmaceuticals
CRNX
|
-0.497 | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Mustang Bio
MBIO
|
-0.00287 | $ 0.39 | 0.15 % | $ 1.91 M | ||
|
TFF Pharmaceuticals
TFFP
|
-0.000577 | - | -60.05 % | $ 125 K | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 1.63 | 1.87 % | $ 2.68 M | ||
|
Mesoblast Limited
MESO
|
1.3 | $ 14.26 | 1.13 % | $ 17.2 B | ||
|
Mirum Pharmaceuticals
MIRM
|
6.53 | $ 93.81 | 0.28 % | $ 4.71 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-0.00126 | - | -15.15 % | $ 60.3 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-0.0315 | - | - | $ 521 M | ||
|
Codexis
CDXS
|
-0.174 | $ 1.09 | 6.37 % | $ 95 M | ||
|
MannKind Corporation
MNKD
|
2.51 | $ 3.91 | 4.0 % | $ 1.2 B | ||
|
MediciNova
MNOV
|
3.01 | $ 1.44 | -0.69 % | $ 70.7 M | ||
|
Axcella Health
AXLA
|
-0.0713 | - | -16.42 % | $ 249 M | ||
|
Merck & Co.
MRK
|
1.18 | $ 146.81 | -0.07 % | $ 367 B | ||
|
Dynavax Technologies Corporation
DVAX
|
-0.688 | - | - | $ 2.02 B | ||
|
Tyme Technologies
TYME
|
-0.0215 | - | 8.07 % | $ 54 M | ||
|
Curis
CRIS
|
-0.00281 | $ 0.88 | 3.67 % | $ 11.6 M | ||
|
Cyclerion Therapeutics
CYCN
|
-0.0574 | $ 34.99 | 3.77 % | $ 147 M | ||
|
Завод ДИОД
DIOD
|
-0.421 | - | - | - | ||
|
CorMedix
CRMD
|
0 | $ 5.31 | 1.43 % | $ 383 K | ||
|
Novartis AG
NVS
|
1.25 | $ 162.64 | 0.44 % | $ 315 B | ||
|
CRISPR Therapeutics AG
CRSP
|
0.0973 | $ 50.09 | 3.15 % | $ 4.5 B | ||
|
PDS Biotechnology Corporation
PDSB
|
3.77 | $ 1.22 | 4.27 % | $ 56.6 M | ||
|
Pfizer
PFE
|
2.76 | $ 29.39 | -0.22 % | $ 167 B | ||
|
Pharming Group N.V.
PHAR
|
-1.94 | $ 12.32 | 0.16 % | $ 8.49 B | ||
|
Orgenesis
ORGS
|
-0.000023 | - | -33.86 % | $ 61.2 M | ||
|
Cytokinetics, Incorporated
CYTK
|
-0.000001 | $ 53.74 | -3.26 % | $ 6.45 M | ||
|
Фармсинтез
LIFE
|
0.297 | - | - | - | ||
|
Prothena Corporation plc
PRTA
|
0.0136 | $ 7.93 | 0.51 % | $ 427 M | ||
|
Codiak BioSciences
CDAK
|
0.0282 | - | -55.98 % | $ 2.15 M | ||
|
DBV Technologies S.A.
DBVT
|
1.56 | $ 10.54 | 7.55 % | $ 1.47 B | ||
|
Rocket Pharmaceuticals
RCKT
|
0.649 | $ 2.38 | -2.05 % | $ 264 M | ||
|
Regeneron Pharmaceuticals
REGN
|
1.08 | $ 904.69 | 0.2 % | $ 94.6 B | ||
|
Replimune Group
REPL
|
-0.204 | $ 21.67 | 8.24 % | $ 2.01 B | ||
|
DiaMedica Therapeutics
DMAC
|
-14 | $ 9.47 | 4.76 % | $ 445 M | ||
|
Royalty Pharma plc
RPRX
|
0.434 | $ 67.31 | -0.39 % | $ 28.9 B | ||
|
Checkpoint Therapeutics
CKPT
|
-0.00928 | - | - | $ 169 M | ||
|
Rhythm Pharmaceuticals
RYTM
|
-19.1 K | $ 111.51 | 6.18 % | $ 7.25 B | ||
|
Puma Biotechnology
PBYI
|
6.48 | $ 8.28 | -15.25 % | $ 414 M | ||
|
SIGA Technologies
SIGA
|
-4.14 | $ 3.12 | 4.55 % | $ 223 M | ||
|
Sage Therapeutics
SAGE
|
0.0153 | - | - | $ 527 M | ||
|
Taro Pharmaceutical Industries Ltd.
TARO
|
-0.277 | - | - | $ 1.62 B | ||
|
Sol-Gel Technologies Ltd.
SLGL
|
-0.218 | $ 61.62 | -2.21 % | $ 172 M | ||
|
SELLAS Life Sciences Group
SLS
|
-0.00162 | $ 8.41 | 6.73 % | $ 917 M | ||
|
Summit Therapeutics
SMMT
|
0.911 | $ 16.34 | 15.15 % | $ 12.2 B | ||
|
Cabaletta Bio
CABA
|
-0.01 | $ 1.3 | 1.17 % | $ 131 M | ||
|
Syndax Pharmaceuticals
SNDX
|
0.084 | $ 9.53 | 1.39 % | $ 826 M | ||
|
Sanofi
SNY
|
15.5 | $ 47.06 | 0.32 % | $ 57.4 B | ||
|
Forma Therapeutics Holdings
FMTX
|
0.233 | - | - | $ 958 M | ||
|
Blueprint Medicines Corporation
BPMC
|
-120 | - | - | $ 8.14 B | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
-0.759 | - | - | $ 26.6 B |